Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
12.12
-0.16 (-1.30%)
Mar 12, 2026, 4:00 PM EDT - Market closed
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $415.17 million as of March 12, 2026. Its market cap has increased by 67.80% in one year.
Market Cap
415.17M
Enterprise Value
227.37M
1-Year Change
67.80%
Ranking
Category
Stock Price
$12.12
Market Cap Chart
Since June 26, 2014, Benitec Biopharma's market cap has decreased from $2.23B to $415.17M, a decrease of -81.36%. That is a compound annual growth rate of -13.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 420.65M | -7.78% |
| Dec 31, 2025 | 456.12M | 55.56% |
| Dec 31, 2024 | 293.22M | 3,429.00% |
| Dec 29, 2023 | 8.31M | 74.68% |
| Dec 30, 2022 | 4.76M | -77.78% |
| Dec 31, 2021 | 21.41M | 61.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Relmada Therapeutics | 442.20M |
| 4D Molecular Therapeutics | 430.00M |
| Anavex Life Sciences | 429.07M |
| vTv Therapeutics | 421.90M |
| PepGen | 416.07M |
| Shattuck Labs | 414.36M |
| Immutep | 408.45M |
| Sutro Biopharma | 406.58M |